Advanced Wound Therapy Device
The recent clinical study by Naik et al, 2019 has demonstrated that WoundExpress is highly effective in reducing the size of ‘hard to heal’ ulcers. In the 21 patient study, the average reduction in wound size was 44% with only 8 weeks of therapy. Most of these wounds were present for more than one year. 48% were of mixed aetiology and 52% were VLUs.
The average VAS pain score also reduced from 34 to 15 with 5% of patients reducing their level of analgesics.
|Consensus Document||Consensus Document||The Benefits of WoundExpress™||Consensus Document - The Benefits of WoundExpress|
|WoundExpress Clinical Paper||WoundExpress™ Clinical paper||Thigh-administered IPC for the treatment of lower limb ulcers||Thigh-administered IPC for the treatment of lower limb ulcers.pdf|
|WoundExpress White Paper||Chronic wound sites by Morris et al||The use of intermittent pneumatic compression of the thigh with the WoundExpress™||785362-1|
|WoundExpress Case Study||Case Studies||9 Clinical Evaluation Results||785865-2|
|Making The Case||Making The Case||Wounds UK Advanced Wound Therapy Paper||Aug 2020|
|Wound Care Today Abstract||Conference Abstracts||Abstracts presented at Wound Care Today Conference||26-27 Feb 2020|
|Posters||Posters||Posters presented at Wound Care Today Conference||26-27 Feb 2020|